Literature DB >> 28669016

Co-infection of Pseudomonas aeruginosa and Stenotrophomonas maltophilia in hospitalised pneumonia patients has a synergic and significant impact on clinical outcomes.

C Yin1, W Yang2, J Meng2, Y Lv2, J Wang2, B Huang3.   

Abstract

Ventilator-acquired pneumonia and hospital community-acquired pneumonia are frequently caused by Gram-negative and -positive bacteria. We noted that pneumonia patients with co-infection of Pseudomonas aeruginosa and Stenotrophomonas maltophilia had a poor clinical outcome. To verify this, we retrospectively reviewed pneumonia cases at Hebei General Hospital from 2010 to 2015. These cases were grouped into four categories: (1) co-infection with P. aeruginosa and S. maltophilia, (2) infection with P. aeruginosa, (3) infection with S. maltophilia and (4) infection with none of the known pneumonia-causing pathogens. The numbers of cases in each group were 50, 40, 41 and 33, with mortality rates of 64.0%, 12.5%, 14.6% and 6.1%, respectively. The analysed results indicated that a co-infection of P. aeruginosa and S. maltophilia had a synergic impact on the mortality of pneumonia patients. Therefore, future research is needed to develop treatment strategies for the co-infected patients to reduce the rate of mortality.

Entities:  

Mesh:

Year:  2017        PMID: 28669016     DOI: 10.1007/s10096-017-3050-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  Ventilator associated pneumonia: perspectives on the burden of illness.

Authors:  D Cook
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

Review 2.  Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

Authors:  Ronald N Jones
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

Review 3.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

Review 4.  The statistics of synergism.

Authors:  B K Slinker
Journal:  J Mol Cell Cardiol       Date:  1998-04       Impact factor: 5.000

Review 5.  Biofilms: Microbial Shelters Against Antibiotics.

Authors:  Skander Hathroubi; Mohamed A Mekni; Philip Domenico; Dao Nguyen; Mario Jacques
Journal:  Microb Drug Resist       Date:  2016-05-23       Impact factor: 3.431

6.  Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.

Authors:  Nadine Hoffmann; Thomas Bovbjerg Rasmussen; Peter Østrup Jensen; Charlotte Stub; Morten Hentzer; Søren Molin; Oana Ciofu; Michael Givskov; Helle Krogh Johansen; Niels Høiby
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

8.  Bacterial pathogens of ventilator associated pneumonia in a tertiary referral hospital.

Authors:  Su Young Chi; Tae Ok Kim; Chan Woo Park; Jin Yeong Yu; Boram Lee; Ho Sung Lee; Yu Il Kim; Sung Chul Lim; Yong Soo Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31

9.  Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.

Authors:  Arianna Pompilio; Valentina Crocetta; Serena De Nicola; Fabio Verginelli; Ersilia Fiscarelli; Giovanni Di Bonaventura
Journal:  Front Microbiol       Date:  2015-09-16       Impact factor: 5.640

10.  Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.

Authors:  Mehrdad Behnia; Sharon C Logan; Linda Fallen; Philip Catalano
Journal:  BMC Res Notes       Date:  2014-04-11
View more
  11 in total

1.  Stenotrophomonas maltophilia Encodes a VirB/VirD4 Type IV Secretion System That Modulates Apoptosis in Human Cells and Promotes Competition against Heterologous Bacteria, Including Pseudomonas aeruginosa.

Authors:  Megan Y Nas; Richard C White; Ashley L DuMont; Alberto E Lopez; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

2.  Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.

Authors:  Melissa S McDaniel; Trenton Schoeb; W Edward Swords
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

3.  Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim-sulfamethoxazole.

Authors:  Jaclyn G McCutcheon; Andrea Lin; Jonathan J Dennis
Journal:  Sci Rep       Date:  2022-06-18       Impact factor: 4.996

Review 4.  Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors:  Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal:  JAC Antimicrob Resist       Date:  2022-05-05

5.  Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion.

Authors:  Léo Franchetti; Desiree M Schumann; Michael Tamm; Kathleen Jahn; Daiana Stolz
Journal:  BMC Infect Dis       Date:  2020-02-01       Impact factor: 3.090

6.  Inter-species interactions alter antibiotic efficacy in bacterial communities.

Authors:  Michael J Bottery; Jessica L Matthews; A Jamie Wood; Helle Krogh Johansen; Jon W Pitchford; Ville-Petri Friman
Journal:  ISME J       Date:  2021-10-09       Impact factor: 10.302

7.  Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.

Authors:  Megan Y Nas; Jeffrey Gabell; Nicholas P Cianciotto
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

Review 8.  The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Jaclyn G McCutcheon; Jonathan J Dennis
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

9.  Identification of pathogen(s) in infectious diseases using shotgun metagenomic sequencing and conventional culture: a comparative study.

Authors:  Huan Chen; Jun Li; Shanshan Yan; Hui Sun; Chuyi Tan; Meidong Liu; Ke Liu; Huali Zhang; Mingxiang Zou; Xianzhong Xiao
Journal:  PeerJ       Date:  2021-06-29       Impact factor: 2.984

10.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.